The AlleyWatch June 2026 New York Venture Capital Funding Report

New York City venture capital surged to $4.70 billion across 81 companies in June 2026, the best month for NYC startup funding on record and more than double May’s total. Unlike prior record months driven by a single outsized raise, June’s total was built on unusual depth at the top: 12 rounds of $100 million or more, led by Ramp’s $750 million financing at a $44 billion valuation. The month’s defining storyline was the arrival of frontier AI research labs as a New York phenomenon, with Flourish emerging from stealth with $500 million backed by Jeff Bezos, Lux Capital, and GV to build brain-inspired AI from a ten-story SoHo lab, and General Intuition announcing $320 million from Khosla Ventures to train action models on gameplay data. NYC captured 24.4% of all US venture dollars in June, its highest share of national funding in at least a year.

NYC Funding by Stage: June 2026

Late-stage capital dominated to a degree rarely seen even in strong months, with 21 deals absorbing 80.4% of all funding at a $100M median. The late-stage cohort’s composition was notable: it included two research labs raising institutional-scale war chests before shipping commercial products, alongside proven revenue-stage companies like Ramp, AlphaSense, and Cyera. Series A activity held steady at 21 deals and a healthy $20M median, while early-stage volume remained the ecosystem’s foundation at 43% of all transactions. The quiet corner was Series B: after May produced nine rounds averaging $50.5M and suggested a maturing 2023-2024 Series A cohort, June delivered only four Series B financings. Whether that reflects a one-month air pocket or companies leapfrogging directly to larger growth rounds will be worth watching in July.

Top 10 NYC Venture Capital Deals: June 2026

Note: Cadence Solutions and Premier Lacrosse League each raised $100M in June, tied just outside the top 10.

The Month NYC Became a Frontier Lab City

June’s most consequential development was not its headline number but who raised it. Flourish, which emerged from stealth on June 4 with $500 million at a $2.5 billion valuation, is a pure research bet: a neuroscience-driven lab founded by CTRL-labs creator Thomas Reardon and former Amazon executive Rob Williams, working to build brain-inspired AI architectures that run on a fraction of the power that transformer models consume. Jeff Bezos anchored the round, with Lux Capital, GV, and Catalio Capital participating, and the company is building out a ten-story facility in West SoHo complete with a wet neuroscience lab and in-house data center.

Three weeks later, General Intuition announced $320 million at a $2.3 billion valuation led by Khosla Ventures, with participation from General Catalyst, Bezos Expeditions, and Eric Schmidt’s Hillspire. Spun out of the gaming clip platform Medal, the company trains world models and action models on billions of action-labeled gameplay clips, betting that human decision-making in games is the richest available dataset for teaching AI to act in physical environments. Both companies are pre-product research organizations valued in the billions, a profile that until recently belonged almost exclusively to the Bay Area. Two such rounds landing in New York in a single month suggests the city’s AI story is expanding beyond applied AI and into foundational model development itself.

The AI theme extended well past the labs. Forty-one of June’s 81 funded companies were identified as AI-focused, capturing $2.61B, or 55.5% of all capital deployed. AlphaSense raised $350 million at a $7.5 billion valuation after crossing $600 million in annual recurring revenue, Cyera added $300 million for its AI-native data security platform, Standard Bots raised $200 million for AI-driven industrial robotics, and Taktile secured $110 million for AI risk decisioning in financial services. Six of the top 10 deals had AI at the core of the product.

Fintech’s Quiet Reassertion

While AI dominated the deal count, the single largest check of the month went to fintech. Ramp’s $750 million financing, led by Iconiq, GIC, and Ontario Teachers’ Pension Plan, set a $44 billion valuation for the seven-year-old spend management platform and accounted for 15.9% of all NYC capital in June. Digital Asset’s $355 million Series F continued the institutional blockchain infrastructure story, backed by a syndicate heavy with banks and market makers as tokenized asset adoption accelerates. Chronograph’s $140M growth equity investment from Sixth Street extended the theme into private markets infrastructure, with the Brooklyn-based portfolio monitoring platform now tracking $5.9 trillion in client capital for institutional LPs and GPs. Together with Taktile, financial technology placed four companies in the top 10, a reminder that New York’s original venture strength remains a compounding engine even as AI absorbs the headlines.

NYC vs. US: June 2026

NYC’s 24.4% share of national venture dollars was the standout comparative statistic of the month, up from 3.0% in May, when Anthropic’s $50B round inflated the national denominator, and above the 21.6% posted in July 2025. NYC’s average deal size of $58.1M ran 29% above the national average, and its $15.0M median was nearly double the US figure, reflecting both the late-stage concentration and the depth of large rounds across the local market. Nationally, June’s $19.27B across 429 companies was led by Baseten’s $1.5B Series F and AppsFlyer’s $1B Series E, with Ramp’s raise ranking as the third-largest round in the country.

Looking Ahead

June closes the first half of 2026 with NYC funding above $16B, already approaching 2025’s full-year total of $19.1B with six months remaining. The question for July is whether the frontier lab momentum compounds: General Intuition is already reported to be in conversations for a Series B, and Flourish’s SoHo buildout will be a magnet for AI research talent that historically defaulted to San Francisco. The Series B gap bears watching in the opposite direction; if May’s nine-deal cohort was a peak rather than a trend, mid-stage companies may face a narrower window between Series A and growth-stage financing. With 12 rounds of $100M or more in a single month and the city’s national funding share at 24.4%, NYC enters the second half of 2026 with as much late-stage gravity as it has had at any point in this cycle.

Methodology

This report analyzes AlleyWatch proprietary funding data (funding.alleywatch.com) for venture rounds announced by NYC-based companies in June 2026, excluding biotech, real estate, lending startups, and debt financings. Funding amounts are classified into four stages: Early-Stage (pre-seed, seed, angel), Series A, Series B, and Late-Stage (Series C and beyond). All figures represent disclosed funding amounts and may not capture undisclosed rounds.